Durata Therapeutics, Inc. Proceeds from Common Stock Issued
Durata Therapeutics, Inc. reported Proceeds from Common Stock Issued of $128.02 million for the 56-month period ending 2014-06-30, per its 10-Q filed 2014-08-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2014-11-07
- Durata Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- Durata Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2013-09-30 was $0.00.
- Durata Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2012-12-31 was $163.00.
- Durata Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2013 was $54.10M, a 26.80% decline from fiscal 2012.
- Durata Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2012 was $73.91M.
| Period end | Proceeds from Issuance of Common Stock 0 month | Proceeds from Issuance of Common Stock | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 6 month as first filed | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 9 month as first filed | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 44 month | Proceeds from Issuance of Common Stock 47 month | Proceeds from Issuance of Common Stock 50 month | Proceeds from Issuance of Common Stock 53 month | Proceeds from Issuance of Common Stock 56 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-06-30 | $128.02M 10-Q · filed 2014-08-07 | |||||||||||||
| 2014-03-31 | $128.02M 10-Q · filed 2014-05-08 | |||||||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $0.00 derived: sum of 2 quarters · filed 2014-11-07 | $54.10M 10-K · filed 2014-03-14 | $128.02M 10-K · filed 2014-03-14 | ||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $54.10M 10-Q · filed 2014-11-07 | $54.10M 10-Q · filed 2013-11-06 | $128.02M 10-Q · filed 2013-11-06 | ||||||||||
| 2013-06-30 | $54.10M 10-Q · filed 2014-08-07 | $54.10M 10-Q · filed 2013-08-07 | $128.02M 10-Q · filed 2013-08-07 | |||||||||||
| 2013-04-17 | $54.10M 10-Q · filed 2014-08-07 | $54.10M 10-Q · filed 2014-11-07 | $54.10M 10-Q · filed 2013-11-06 | |||||||||||
| 2012-12-31 | $163.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $73.91M 10-K · filed 2014-03-14 | ||||||||||||
| 2012-09-30 | $73.91M 10-Q · filed 2013-11-06 |